title: Dengue vaccines: problems and prospects.
abstract: The extent of cumulative disease burden caused by dengue virus has attained an unprecedented level in recent times with sharp increase in the size of human population at risk. Dengue disease presents highly complex medical, economic and ecologic problems. The surge in publications on the development of dengue vaccines, taking advantage of new generation of biotechnology techniques indicates the profound interest and urgency in the scientific and medical communities in combating this disease. This review summarizes the importance of critical subjects like pathogenesis of dengue haemorrhagic fever and inadequacy of animal model that have adversely affected dengue vaccine development. Further, the remarkable progresses so far made in dengue vaccine research not only employing a diverse range of new strategies but also re-using old techniques to improve the existing vaccines, have been presented. The efficacy and safety of some of the new vaccine candidates have been evaluated and proven in human preclinical/clinical trials. Besides the technical advancement in vaccine development, vaccine safety and vaccine formulation have been examined.
authors.affiliation: K.G. Medical University, Lucknow, India.
authors.forename: U C
authors.initials: UC
authors.lastname: Chaturvedi
authors.forename: Richa
authors.initials: R
authors.lastname: Shrivastava
authors.forename: Rachna
authors.initials: R
authors.lastname: Nagar
mesh_terms: D000818:Animals; D016207:Cytokines / Q000378:metabolism; D003715:Dengue / Q000276:immunology / Q000503:physiopathology* / Q000517:prevention & control*; D003716:Dengue Virus / Q000276:immunology*; D004195:Disease Models, Animal; D015195:Drug Design; D006801:Humans; D008954:Models, Biological; D015164:Vaccines, Inactivated / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology; D014765:Viral Vaccines
chemical_list: D016207:Cytokines; D015164:Vaccines, Inactivated; D014614:Vaccines, Synthetic; D014765:Viral Vaccines